New York Bio's Patient Engagement Summit: Role of Rare Panel
Role of Rare Panel - Tuesday, March 21st
In the 40 years since the Orphan Drug Act, rare disease innovation and advocacy has come a long way. In this panel, we will discuss biotechnology centered on rare disease and why innovation in the rare disease space is so important for finding cures and treatments.
Join us Tuesday, March 21st for our Patient Engagement Summit, held with both in-person and virtual attendance options.
NewYorkBIO partners with patient advocacy groups to connect leaders in the patient community with leaders in the biotech and life science fields. The Summit features panel discussions with representatives from across the the patient and life science ecosystems. NewYorkBIO focuses on linking patients with companies and researchers who work to discover and develop treatments and cures.